SS
INO icon

SBI Securities’s Inovio Pharmaceuticals INO Stock Holding History

SBI Securities’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5K Buy
6,814
+1,411
+26% +$1.67K ﹤0.01% 1980
2026
Q1 		$9.4K Buy
5,403
+1,137
+27% +$1.87K ﹤0.01% 1752
2025
Q4 		$7.42K Sell
4,266
-43
-1% -$95 ﹤0.01% 1861
2025
Q3 		$10.1K Buy
4,309
+130
+3% +$249 ﹤0.01% 1774
2025
Q2 		$8.5K Buy
4,179
+21
+0.5% +$40 ﹤0.01% 1773
2025
Q1 		$6.78K Buy
4,158
+44
+1% +$88 ﹤0.01% 1771
2024
Q4 		$7.53K Buy
+4,114
New +$18.2K ﹤0.01% 1760

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Securities's INO Position: Q2 2026 in Review

SBI Securities increased its Inovio Pharmaceuticals (INO) stake by 26% in Q2 2026, buying an estimated $1.67K and bringing the position to 6,814 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

SBI Securities first reported a position in INO in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.1K in Q3 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • SBI Securities held 6,814 shares of Inovio Pharmaceuticals worth $7.5K as of Q2 2026.
  • SBI Securities bought 1,411 Inovio Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
  • Inovio Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1980 holding.
  • SBI Securities first reported a position in Inovio Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Inovio Pharmaceuticals position peaked at $10.1K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.